Group I | Group II | Group III | p | ||||
---|---|---|---|---|---|---|---|
Avg. ± s.s. | Median | Avg. ± s.s. | Median | Avg. ± s.s. | Median | ||
Rest VAS | |||||||
Pretreatment | 5.2 ± | 5.0 | 5.8 ± 1.3 | 6.0 | 5.1 ± 1.2 | 5.0 | 0.308 |
Post-Injection | 2.0 ± | 2.0 | 3.0 ± 1.6 | 4.0 | 1.3 ± 1.1 | 1.0 | 0.056 |
1st week | 3.8 ± | 4.0 | 3.2 ± 1.3 | 4.0 | 1.8 ± 1.3 | 1.0 | 0.006 |
4th week | 3.8 ± | 4.0 | 1.9 ± 1.8 | 1.0 | 1.0 ± 0.9 | 1.0 | 0.001 |
3rd month | 4.1 ± | 4.0 | 1.7 ± 1.7 | 1.0 | 0.3 ± 0.5 | 0.0 | 0.000 |
Movement VAS | |||||||
Pretreatment | 7.2 ± 1.0 | 7.0 | 7.4 ± 1.0 | 8.0 | 7.1 ± 0.9 | 7.0 | 0.539 |
Post-Injection | 3.5 ± 1.6 | 4.0 | 4.4 ± 2.2 | 5.0 | 2.6 ± 1.3 | 2.0 | 0.069 |
1st week | 5.8 ± 0.9 | 6.0 | 4.7 ± 1.7 | 5.0 | 3.1 ± 1.6 | 3.0 | 0.003 |
4th week | 5.7 ± 0.8 | 5.0 | 2.9 ± 2.2 | 2.0 | 1.7 ± 1.5 | 2.0 | 0.000 |
3rd month | 6.0 ± 1.1 | 6.0 | 2.8 ± 1.9 | 2.0 | 0.9 ± 1.1 | 1.0 | 0.000 |
Beck Depresion | |||||||
Pretreatment | 27.6 ± 8.2 | 30.5 | 37.2 ± 7.5 | 35.0 | 29.9 ± 12.3 | 28.0 | 0.101 |
1st month | 26.4 ± 7.2 | 29.0 | 34.7 ± 7.2 | 35.0 | 25.9 ± 12.6 | 26.0 | 0.133 |
3rd month | 26.1 ± 5.0 | 27.0 | 30.0 ± 6.2 | 30.0 | 23.2 ± 12.2 | 22.0 | 0.367 |
OSWESTRY Score | |||||||
Pretreatment | 37.8 ±3.5 | 39.0 | 38.0 ± 5.7 | 38.0 | 40.6± 3.5 | 39.0 | 0.446 |
1st month | 35.1 ± 3.8 | 35.5 | 35.1 ± 5.1 | 35.0 | 24.6 ± 5.8 | 24.0 | 0.002 |
3rd month | 34.9 ± 4.7 | 36.5 | 31.1 ± 4.4 | 32ç0 | 18.1 ± 4.2 | 19.0 | 0.000 |
Kruskal-wallis (Mann-whitney u test) |